These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 9175047

  • 1. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI, Bagriy AE, Lebed IA, Yarovaya NF, Schukina EV, Taradin GG.
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [Abstract] [Full Text] [Related]

  • 2. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW.
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [Abstract] [Full Text] [Related]

  • 3. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI, Bagriĭ AE, Lebed' IA, Iarovaia NF, Shchukina EV, Gaĭdukov VO, Gritsenko PV, Diadyk IA.
    Ter Arkh; 1997 May; 69(6):24-7. PubMed ID: 9297267
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H, Manabe K, Fukuda K, Abe M, Ito S.
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [Abstract] [Full Text] [Related]

  • 5. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, Walker JF, Hahn RT, Dahlöf B.
    Circulation; 2001 Sep 11; 104(11):1248-54. PubMed ID: 11551875
    [Abstract] [Full Text] [Related]

  • 6. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).
    Palmieri V, Bella JN, DeQuattro V, Roman MJ, Hahn RT, Dahlof B, Sharpe N, Lau CP, Chen WC, Paran E, de Simone G, Devereux RB.
    Am J Cardiol; 1999 Sep 01; 84(5):558-62. PubMed ID: 10482155
    [Abstract] [Full Text] [Related]

  • 7. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan 01; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
    Scognamiglio R, Nosadini R, Marin M, Nisti S, Fasoli G, Palisi M, Frigato F, Virgili F, Carraro A, Crepaldi G.
    Diabetes Care; 1997 Aug 01; 20(8):1290-2. PubMed ID: 9250456
    [Abstract] [Full Text] [Related]

  • 9. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
    Oren S, Grossman E, Frohlich ED.
    Am J Cardiol; 1996 Jan 01; 77(1):93-6. PubMed ID: 8540468
    [Abstract] [Full Text] [Related]

  • 10. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R, Irace L, Perna B, Caruso C, Guida M, Iacono A.
    Minerva Cardioangiol; 1993 May 01; 41(5):205-9. PubMed ID: 8355860
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED.
    Am J Hypertens; 1988 Jul 01; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [Abstract] [Full Text] [Related]

  • 12. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR, Abdulzahra MS, Al-Huseini LM, Al-Aubaidy HA.
    Int J Cardiol; 2017 Mar 01; 230():269-274. PubMed ID: 28041700
    [Abstract] [Full Text] [Related]

  • 13. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 Mar 01; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 14. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E, Reid C, Qi XL, Jennings GL.
    Clin Exp Pharmacol Physiol; 1998 Mar 01; 25(3-4):208-15. PubMed ID: 9590570
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P, Roudaut R, Herrero G, Dallocchio M.
    J Cardiovasc Pharmacol; 1990 Mar 01; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [Abstract] [Full Text] [Related]

  • 16. Acute filling pattern changes of the failing left ventricle after captopril as related to ventricular structure.
    Barbier P, Tamborini G, Alioto G, Pepi M.
    Cardiology; 1996 Mar 01; 87(2):153-60. PubMed ID: 8653733
    [Abstract] [Full Text] [Related]

  • 17. Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor?
    Skoularigis J, Strugo V, Zambakides C, Eintracht S, Reddy K, Tshele E, Smith D, Sareli P.
    Int J Clin Pharmacol Ther; 1996 Jun 01; 34(6):263-8. PubMed ID: 8793612
    [Abstract] [Full Text] [Related]

  • 18. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG, Crozier IG, Turner JG, Richards AM, Frampton CM, Nicholls MG, Ikram H.
    Am J Cardiol; 1994 Jun 15; 73(16):1180-6. PubMed ID: 8203335
    [Abstract] [Full Text] [Related]

  • 19. Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
    Magometschnigg D, Brandt D, Hofmann R, Sihorsch K, Stoschitzky K, Zangeneh M, Zenker G.
    Int J Clin Pharmacol Ther; 1997 Sep 15; 35(9):389-96. PubMed ID: 9314093
    [Abstract] [Full Text] [Related]

  • 20. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
    Dahlöf B, Hansson L.
    J Hypertens; 1992 Dec 15; 10(12):1513-24. PubMed ID: 1338083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.